AAPL 186.2 -1 (-0.53%)MSFT 115.68 -1.29 (-1.10%)FB 166.03 -0.08 (-0.05%)ZNGA 5.37 -0.04 (-0.83%)NVDA 169.95 -0.19 (-0.11%)WBA 62.59 +0.41 (+0.66%)GOOG 1184.6 -10.72 (-0.90%)PIH 5.63 +1.49 (+35.99%)
AAPL 186.2 -1 (-0.53%)MSFT 115.68 -1.29 (-1.10%)FB 166.03 -0.08 (-0.05%)ZNGA 5.37 -0.04 (-0.83%)NVDA 169.95 -0.19 (-0.11%)WBA 62.59 +0.41 (+0.66%)GOOG 1184.6 -10.72 (-0.90%)PIH 5.63 +1.49 (+35.99%)

Financial Statements KALV Quote KalVista Ph

All | Income Statement | Balance Sheet | Cash Flow | Retained Earnings | PPE Schedule | Intangible and Goodwill Schedule
Income Statement
Year 201420152016
Revenue 2 2 8
COGS 0 0 0
GrossProfit 2 2 8
Depreciation (included in COGS) 0 0 0
StockBasedCompe (included in COGS) 0 0 1
ResearchAndDeve 15 13 18
SalesGeneralAnd 3 11 9
OperatingIncome -15 -22 -19
InterestExpense 0 0 0
OtherIncome 4 4 3
IncomeBeforeTax -11 -19 -16
ProvisionForInc 0 0 0
NetIncome -11 -19 -16
Balance Sheet
Year 201420152016
CashAndCashEqui 22 31 51
ShortTermInvest 0 0 0
Cash 22 31 51
AccountReceivab 2 3 7
Inventories 0 0 0
DeferredIncomeT 0 0 0
OtherCurrentAss 0 0 0
TotalCurrentAss 25 34 59
PPE 0 0 2
AccumulatedDepr 0 0 -1
NetPPE 0 0 2
EquityAndOtherI 0 0 0
Goodwill 0 0 0
IntangibleAsset 0 0 0
OtherLTAssets 0 0 0
TotalNonCurrent 0 0 2
TotalAssets 25 34 61
ShortTermDebt 0 0 0
AccountsPayable 1 1 1
TaxesPayable 0 0 0
AccruedLiabilit 1 1 2
DeferredRevenue 0 0 18
OtherCurrentLia 1 1 1
TotalCurrentLia 3 3 23
Debt 0 0 0
DeferredTaxesLi 0 0 0
DeferredRevenue 0 0 0
OtherLTLiabilit 59 0 11
TotalNonCurrent 59 0 11
TotalLiabilitie 62 3 34
CommonStock 0 0 0
AdditionalPaidI 0 90 100
RetainedEarning -37 -56 -72
AccumulatedOthe 0 -3 -1
TotalStockholde -37 31 27
TotalLiabilitie 25 34 61
Cash Flow Statement
Year 201420152016
NetIncome -11 -19 -16
Depreciation 0 0 0
DeferredIncomeT 0 0 0
StockBasedCompe 0 0 1
AccountsReceiva 0 0 0
InventoryCS 0 0 0
AccountsPayable 0 -2 0
OtherWorkingCap -1 -1 25
OtherNonCashIte -2 -1 -1
NetCashProvided -13 -24 11
InvestmentsInPP 0 0 -1
AcquisitionsNet 0 0 0
PurchasesOfInve 0 0 0
SalesMaturities 0 0 0
PurchasesOfInta 0 0 0
OtherInvestingA 0 34 0
NetCashUsedForI 0 34 -1
DebtIssued 0 0 0
DebtRepayment 0 0 0
CommonStockIssu 0 0 9
CommonStockRepu 0 0 0
DividendPaid 0 0 0
OtherFinancingA 0 0 0
NetCashProvided 33 0 9
NetChangeInCash 19 9 20
CashAtBeginning 3 22 31
CashAtEndOfPeri 22 31 51
Retained Earnings
Year 201420152016
RetainedEarning --48-73
NetIncome -7-25-11
StockDividend -50-25
DividendPaid ---
RetainedEarning -48-73-37
Property Plant and Equipment Schedule
Year 201420152016
NetPPE --1
DeprAnnual 0-11
CapitalExpendit 010
NetPPE -1-
Intangible and Goodwill Schedule
Year 201420152016
intAndGW 0--
Amortization 01-1
NewPurchases 0-11
intAndGW ---
KalVista Pharmaceuticals Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes KalVista Pharmaceuticals Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.